BICYCLE THERAPEUTICS plc·4

Aug 27, 6:31 PM ET

Kalowski Lee 4

4 · BICYCLE THERAPEUTICS plc · Filed Aug 27, 2021

Insider Transaction Report

Form 4
Period: 2021-08-26
Kalowski Lee
President and CFO
Transactions
  • Sale

    Ordinary Shares

    2021-08-26$35.04/sh550$19,2720 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-08-277,9505,768 total
    Exercise: $8.73Exp: 2029-03-07Ordinary Shares (7,950 underlying)
  • Sale

    Ordinary Shares

    2021-08-27$35.15/sh7,950$279,4430 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-08-2655013,718 total
    Exercise: $8.76Exp: 2029-03-07Ordinary Shares (550 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2021-08-26$8.76/sh+550$4,818550 total
  • Exercise/Conversion

    Ordinary Shares

    2021-08-27$8.73/sh+7,950$69,4047,950 total
Footnotes (6)
  • [F1]Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5).
  • [F4]This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.18 inclusive.
  • [F6]25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION